Cell Point (India) (NSE:CELLPOINT) EBIT : ₹85 Mil (TTM As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Cell Point (India) EBIT?

Cell Point (India)'s earnings before interest and taxes (EBIT) for the six months ended in Mar. 2024 was ₹26 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹85 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Cell Point (India)'s annualized ROC % for the quarter that ended in Mar. 2024 was 0.07%. Cell Point (India)'s annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 7.24%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Cell Point (India)'s Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 8.71%.

Cell Point (India) EBIT Historical Data

The historical data trend for Cell Point (India)'s EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cell Point (India) EBIT Chart

Cell Point (India) Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Mar24

EBIT

50.31

38.75

40.30

183.99

84.63

Cell Point (India) Semi-Annual Data
	Mar20	Mar21	Mar22	Sep22	Mar23	Sep23	Mar24
EBIT	Get a 7-Day Free Trial			-	93.18	-	58.14	26.49

Competitive Comparison of Cell Point (India)'s EBIT

For the Specialty Retail subindustry, Cell Point (India)'s EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cell Point (India)'s EV-to-EBIT Distribution in the Retail - Cyclical Industry

For the Retail - Cyclical industry and Consumer Cyclical sector, Cell Point (India)'s EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Cell Point (India)'s EV-to-EBIT falls into.

Cell Point (India) EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹85 Mil.

Cell Point (India) (NSE:CELLPOINT) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Cell Point (India)'s annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

	ROC % (Q: Mar. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Sep. 2023 )	+	Invested Capital (Q: Mar. 2024 ))	/ count )
=	50.294 * ( 1 - 98.55% )	/	( (1047.372	+	1142.402)	/ 2 )
=	0.729263	/	1094.887
=	0.07 %

where

	Invested Capital		(Q: Sep. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	1290.576	-	152.756	-	( 90.448	-	max(0, 528.144	-	698.019	+	90.448	))
=	1047.372

	Invested Capital		(Q: Mar. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	1341.182	-	91.913	-	( 120.013	-	max(0, 603.848	-	710.715	+	120.013	))
=	1142.402

Note: The Operating Income data used here is two times the semi-annual (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Cell Point (India)'s annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Mar. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Sep. 2023		Q: Mar. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	52.984	/	( ( (297.069 + max(379.889, 0))	+	(332.164 + max(454.523, 0)) )	/	2 )
=	52.984	/	( ( 676.958	+	786.687 )	/	2 )
=	52.984	/	731.8225
=	7.24 %

where Working Capital is:

	Working Capital		(Q: Sep. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(6.129	+	533.83	+	44.089)	-	(152.756	+	0	+	51.403)
=	379.889

	Working Capital		(Q: Mar. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(4.012	+	550.923	+	26.711)	-	(91.913	+	0	+	35.21)
=	454.523

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Cell Point (India)'s Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Mar. 2024 )
	=	84.634	/	971.406
	=	8.71 %

Cell Point (India) EBIT Related Terms

Thank you for viewing the detailed overview of Cell Point (India)'s EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Cell Point (India) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Retail - Cyclical » Cell Point (India) Ltd (NSE:CELLPOINT) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ward No. 27, Ram’s Arcade, Door No. 30-15-139, Room No. 5 and 6, Opposite Visakha Medical Centre, Dabagardens, Visakhapatnam, AP, IND, 530020

Website

https://www.cellpoint.biz

Cell Point (India) Ltd is engaged in multi-brand retail selling of Smart Phones, tablets, mobile accessories, and mobile-related products and allied accessories of various brands such as Apple, Samsung, Oppo, Realme, Nokia, Vivo, Xiaomi, Nokia, Redmi, Techno, One Plus, GIONEE, VIVO, etc. It is also engaged in retail selling of some of the consumer durable electronics goods, specifically, smart televisions of various brands such as Xiaomi, Realme, and One Plus. The company also provides payment options such as credit/EMI facilities including UPI, vouchers, & pay-on-delivery to its customers for buying its products for which the company has tied up with major leading credit houses.

Cell Point (India) Headlines

No Headlines